Form Type and Filing Date: This is a Form 8-K Current Report filed by Humana Inc. on September 1, 2026, reporting events as of that same date. Item Being Reported: The filing is submitted under Item 7.01 - Regulation FD Disclosure, indicating the company is making a disclosure that is intended for public dissemination. Company Information: Humana Inc. is a Delaware-incorporated hospital and…

Our analysis rates this filing BULLISH. Humana's 8-K filing presents a fundamentally positive picture with minimal material concerns. The company is reaffirming full-year 2026 guidance across both GAAP and Adjusted EPS metrics without any cuts or reductions, which is a strong signal of business…

Concern level: MODERATE (2.2/10). Key factors: Management acknowledges potential future changes to GAAP EPS guidance due to ongoing value creation initiatives, introducing some uncertainty around near-term earnings trajectory; Delayed commentary on 2027 Medicare Advantage Star Ratings until October CMS release creates a near-term information gap, though this is standard disclosure practice;…

Notable risk changes: FY 2026 guidance reaffirmed: at least $6.52 GAAP EPS and at least $9.00 Adjusted EPS - no changes from July 29, 2026 guidance; Company expects potential changes to FY 2026 GAAP EPS guidance due to ongoing value creation and strategic initiatives, but no changes expected to Adjusted EPS guidance; Delayed 2027 Medicare Advantage Star Ratings commentary until October CMS release - standard…